Anavex Life Sciences Corp. (AVXL) announced promising preliminary electroencephalography or EEG biomarker results from Part A of its ...

Those who had both depression and concussion reported nearly twice as many symptoms of depression as those who had either ...

A new Northwestern Medicine study has demonstrated a new way to treat narcolepsy-related nightmares. The scientists combined ...

Firefly Neuroscience partners with Bright Minds Biosciences to analyze positive Phase 1 data of BMB-101 using advanced AI ...

A new study has demonstrated a new way to treat narcolepsy-related nightmares. The scientists combined cognitive behavioral therapy (CBT) and lucid dreaming to help patients in a small clinical trial.

A new study reveals that athletes with both concussion and depression face significantly worse symptoms for both conditions ...

Bright Minds Biosciences Inc (NASDAQ:DRUG) shares are trading higher again after soaring last week. The company on Monday ...

The following is a summary of “Allopregnanolone and progesterone in relation to a single electroconvulsive therapy seizure ...

A new Northwestern Medicine study has demonstrated a new way to treat narcolepsy-related nightmares. The scientists combined ...

Part A of the Phase 2 study ANAVEX ® 3-71-SZ-001 ( NCT06245213 ), was a multiple ascending dose study in 16 participants treated with either oral placebo, oral ANAVEX ® 3-71 90 mg daily, or oral ...